
P909: RENAL RESPONSE OF POMALIDOMIDE WITH BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT
Author(s) -
Jian Y.,
Chang L.,
Shi M.,
Sun Y.,
Chu X.,
Xue H.,
Shen X.,
Ma J.,
Jia G.,
Feng Y.,
Xi Z.,
Zhao Y.,
Ma Y.,
Xiao J.,
Ma G.,
Wang Q.,
Huang W.,
Bao L.,
Dong Y.,
Zhou H.,
Sun C.,
Su G.,
Yan Y.,
Saiyin Q.,
Su L.,
Gao S.,
Tian W.,
Sun X.,
Jing H.,
Gao D.,
Chen W.,
Li J.,
Gao W.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846508.48688.f4
Subject(s) - medicine , pomalidomide , bortezomib , multiple myeloma , transplantation , lenalidomide , autologous stem cell transplantation , clinical endpoint , oncology , surgery , clinical trial